Professor Yury Gogotsi , Drexel University, USA, received an Honorary Doctorate from Frantsevich Institute for Problems of Materials Science, National Academy of Science of Ukraine.
Deputy Directors of IPMS NAS professors Dr. Firstov, Dr. Ragulya, Dr. Baglyuk, and Mr. Zavorotnyi and Scientific Secretary Dr. Kartuzov participated in the ceremony. This is just the fifth Honorary Doctor of IPMS NAS certificate issued in the history of the Frantsevich Institute for Problems of Materials Science, NASU.
Last position of Yury Gogotsi in Ukraine, before his Humboldt Fellowship, was at this institute. He also received his Dr. Sci. Degree in Materials Engineering from this institute. It used to be the leading materials science research center in the former Soviet Union.
Institute for Problems in Materials Science (IPMS) is Ukrainian leading centre of advanced scientific and engineering services, technical consulting and contract research and development in the field of Material science and advanced technology of metal, ceramic and composite materials IPMS was set up in 1955 on the base of the laboratory for special alloys of the Ukrainian Academy of Sciences. Since then it has progressively widened its fields of application and customer base. IPMS has no analogues among academic institutions due a great variety of new developments in technological processes, materials and products on their base.. IPMS employs about 1700 people, including 70 doctors and more than 345 Ph.D., among them Members of Ukrainian Academy of Sciences, professors.
IPMS is a large scientific and research complex, including Special Design Bureau with Pilot Plants, Computer Centre and Laboratory for Basalt Materials Production. All achievements in the development of new materials with their further commercial application are supported by wide basic researches in the field of solid-state physics and chemistry, inorganic physical chemistry, mechanics of deformable media. IPMS' scientists are expanding the national activity collaborating with different companies from the U.S.A., United Kingdom, France, Germany, Yugoslavia, Poland, Hungary, Bulgaria, Austria, Switzerland, Mexico, India, Cuba, South Korea, Israel, Japan, China etc. IPMS sells licenses on the advanced technologies as, well as set up Joint Ventures for the production of cutting tools, wear and corrosion resistant coatings using detonation spraying technique, ceramics for electrical application, ceramic powders of high purity. Institute has set up service centres operating on the base of the detonation coating technology in Japan, China, Yugoslavia, Iran.
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
